K945549

Substantially Equivalent

ABUSIGN(TM) DOA 4, DOA, THC/OPI/COC/AMP OR MET, BIOSIGN(TM) DOA 4, THC/OPI/COC/AMP OR MET

Applicant: Princeton BioMeditech Corp.
Product code: DIO
Advisory panel: Clinical Toxicology
Date received: 1994-11-14
Decision date: 1995-10-26
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Princeton, NJ, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.